Objective-The association between obesity and cardiovascular disease and venous thromboembolism might, at least partially, be explained by a hypercoagulable state. The extent to which body fat mass and its distribution contribute to a hypercoagulable state is unknown. In this study, we investigated the association between body composition and thrombin generation and evaluated the potential mediating role of low-grade inflammation. Methods and Results-We studied 586 individuals from the Hoorn Study (mean age, 69.7Ϯ6.5 years, 298 women) in whom body composition was assessed by whole body dual-energy absorptiometry. Thrombin generation was measured using the Calibrated Automated Thrombogram. Multiple regression analyses showed a positive association between total body fat and thrombin generation in women but not in men. In addition, detailed analyses of regional body composition showed that central but not peripheral fat mass was associated with greater thrombin generation and that there was a trend toward an inverse association with peripheral lean mass. The reported positive associations were partially attenuated by low-grade inflammation, however. Conclusion-Body fat mass, in particular a central pattern of fat distribution, is associated with higher levels of thrombin generation in elderly women but not in men. This association may partially be explained by adiposity-related low-grade inflammation, but this hypothesis needs to be further investigated in mechanistic/prospective studies. (Arterioscler
O besity, in particular central obesity, is associated with cardiovascular disease (CVD). 1, 2 Recent evidence also suggests an association between (central) obesity and incident venous thromboembolism. 3, 4 One proposed mechanism that could explain these associations, at least in part, is a hypercoagulable state in obese individuals. 5 Indeed, thrombin is one of the key players in the coagulation cascade, 6 and in vivo markers of thrombin generation have been positively associated with waist circumference in postmenopausal women. 7 Recently, several new methods have become available that quantitatively measure thrombin generation in vitro after activation of the coagulation cascade with tissue factor (TF), phospholipids, and calcium chloride (CaCl 2 ). 8 The Calibrated Automated Thrombogram (CAT) method is one such method. 9 Specifically, it generates a thrombin generation curve that mimics the overall plasma coagulability potential when a thrombogenic stimulus appears ( Figure 1A ). This curve is characterized by a lag (initiation) phase, followed by a thrombin burst (propagation), which is then eventually completely inhibited by plasma protease inhibitors (termination). The endogenous thrombin potential (ETP), or the area under this curve, represents the total amount of active thrombin that is formed after activation of the coagulation cascade. The ETP has been shown to be a good indicator of a hypercoagulable state in, for example, individuals using oral contraceptives or with (prior) venous thromboembolism or circulating lupus anticoagulants. 9 -12 Evidence so far linking obesity to an individual's coagulation potential assessed by this new method is very scarce and confined to children and adults with morbid obesity. 13, 14 In addition, the extent to which total fat mass and its distribution contribute to or protect against a hypercoagulable state is not known. It is also unknown what adiposity-related underlying mechanisms may explain any such associations, but low-grade inflammation is a likely candidate in this regard. Indeed, levels of high-sensitivity C-reactive protein (hsCRP) are increased in overweight and obese individuals, 15 and in vivo, C-reactive protein infusion has been associated with increased thrombin generation (assessed by activation markers). 16 In view of these considerations, we investigated, in a large population-based cohort, the association between body composition and thrombin generation in plasma and evaluated whether any such associations were independent of other "traditional" cardiovascular risk factors, such as hypertension, dyslipidemia, smoking, and glucose metabolism status. In addition, we evaluated the potential "mediating" role of hsCRP in any such associations.
Methods

Study Population
The Hoorn Study is a population-based cohort study of glucose metabolism and its complications, which started in 1989, as described in detail elsewhere. [17] [18] [19] Briefly, a random sample of 50-to 75-year-old subjects was taken from the population register of Hoorn (59,000 inhabitants) in the Netherlands. Of the 3553 subjects invited, 2540 (71.5%) agreed to participate, of whom 56 were excluded from analyses because they were nonwhite. The original Hoorn Study cohort thus consisted of 2484 subjects. 18 Between 1996 and 1998, a 2nd examination (1st follow-up) was carried out. From the initial cohort, 150 people had died and 108 had moved out of Hoorn before 1996. One hundred forty other people were not invited because of logistical reasons. Of the remaining 2086 people who were invited for the follow-up examination, 1513 (72.5%) participated. 17 In 2000 -2001, a 3rd examination was carried out among surviving participants who gave their permission to be recontacted. Specifically, we invited all participants who had diabetes, as determined by a 75-g oral glucose tolerance test or by diabetes treatment (nϭ176), and a random sample of participants who had normal (nϭ705) or impaired glucose tolerance (nϭ193) at the 2nd examination. Of the 1074 individuals invited, 648 (60.3%) participated. The main reasons for nonparticipation in the 2000 -2001 follow-up examination were lack of interest (30%) or comorbidity (23%). Other reasons were high age (7%), unwillingness to travel (6%), participation considered too time-consuming (6%), and miscellaneous reasons (15%); 13% gave no reason. 19 Detailed measurements of participants' body composition by means of dual-energy x-ray absorptiometry (DXA) and thrombin generation parameters were obtained, for the first time, during the 3rd examination. Therefore, for the present study, cross-sectional analyses of data from this examination were conducted. We excluded 62 participants from the analyses for the following reasons: use of cumarin derivatives (nϭ24), and/or use of hormonal replacement therapy (n2), and/or missing data on thrombin generation tests (n31), and/or missing data on DXA measurements (nϭ25). The present study therefore consisted of 586 individuals.
The Ethical Review Committee of the Vrije Universiteit University Medical Centre approved the study protocol, and all participants gave their written informed consent.
Anthropometrics/Body Composition
Weight and height were measured while participants were barefoot, wearing only light clothing. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Waist circumference was measured at the level midway between the lowest rib margin and the iliac crest, and hip circumference was measured at the widest level over the greater trochanters.
A whole body DXA scan was performed using the fan beam technology (QDR-2000, software version 7.20D, Hologic, Brussels, Belgium). This software provides estimates of lean tissue mass, fat mass, and bone mineral mass for the total body and for standard body regions. Regions of the head, trunk, arms, and legs were distinguished with the use of specific anatomic landmarks. 19 In the analyses, we used fat and lean soft tissue mass from the trunk, arms, and legs. Peripheral fat was calculated by adding the fat mass of the legs to that of the arms, and peripheral lean mass was calculated by adding the lean mass of the legs to that of the arms. 20 
Thrombin Generation Parameters
Venous blood samples were collected in 2000 -2001, and 3.2% citrated platelet-poor plasmas were prepared by 2-step centrifugation: at 4000g for 15 minutes followed by centrifugation at 10 000g for 5 minutes. Plasmas were stored at Ϫ80°C until analysis in 2008 and were not thawed before then. Thrombin generation in plateletpoor plasma was measured using the CAT method, 9 which uses low-affinity fluorogenic substrate for thrombin (Z-Gly-Gly-Arg-AMC) to continuously monitor thrombin activity in clotting plasma. Thrombin generation was assessed according to manufacturer's instructions (Thrombinoscope BV) in a 96-well plate fluorometer (Ascent Reader, Thermolabsystems OY, Helsinki, Finland) as previously described. 21 Briefly, thrombin generation was determined in the presence of: 1 pM TF and 4 M phospholipids in the absence and presence of 0.55 nM recombinant soluble thrombomodulin (Paion GmbH, Aachen, Germany). The 1 pM TF trigger was a commercial product (PPP Reagent Low, Thrombinoscope BV, Maastricht, the . Those who were overweight had 0.2%, 10.4%, and 6.3% longer/higher lag time, peak height, and ETP, respectively, and those with obesity had 5.2%, 14.6%, and 8.4% longer/higher lag time, peak height, and ETP, respectively, compared with those with normal weight (P for trend, Ͻ0.04 for all).
Netherlands). Three parameters were derived from these analyses: lag time (min), peak height (nM), and ETP [nM] . Finally, a thrombomodulin ratio was calculated by dividing the ETP and peak height obtained in the presence by those in the absence of thrombomodulin. Thrombomodulin activates the anticoagulant protein C pathway, and therefore this ratio represents the inhibition of thrombin generation by activation of the protein C pathway. At our laboratory, the intraassay coefficients of variation (CVs) are Ͻ5%, 21 and the interassay CVs, obtained in 2 lots of normal-pool plasma in 25 independent runs during the present study, were Results are expressed as meanϮSD, frequencies (%), or medians (interquartile range). NGM: indicates normal glucose metabolism; IGM: impaired glucose metabolism; DM2: type 2 diabetes; TM: thrombomodulin.
*P for trend.
Ͻ11% for all thrombin generation parameters (calculated using EP Evaluator 8.0.0.90 software).
Other Measurements
Health status, medical history, medication use, and smoking habits were assessed by questionnaires. 18 Systolic blood pressure (SBP) and diastolic blood pressure, levels of plasma glucose (fasting and postload), insulin, total, high-and low-density lipoprotein cholesterol, triglycerides, and hsCRP were measured as described elsewhere. 19 In addition, urinary albumin-to-creatinine ratio was measured in an early morning first-voided urine sample, and accordingly, participants were classified as having microalbuminuria if the albumin-to-creatinine ratio was 2.0 to 30 mg/mmol. Hypertension was defined as SBP Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg, or the use of antihypertensive drugs. 22 Prior CVD was defined when individuals had any of the following: a history of myocardial infarction, transient ischemic attack or ischemic stroke, abnormalities on a resting ECG (Minnesota codes 1.1 to 1.3, 4.1 to 4.3, 5.1 to 5.3, or 7.1), undergone coronary bypass surgery or angioplasty, peripheral arterial bypass or nontraumatic amputation, or ankle-brachial index of Ͻ0.9 in either leg.
Statistical Analyses
Comparisons of the clinical characteristics according to sex were investigated with the use of the Student t test for continuous variables and 2 test for frequency data. We used multiple linear regression analyses to investigate the associations between body composition and thrombin generation parameters. First, associations with DXA and anthropometric estimates of total body fat were examined. These analyses were adjusted for age, prior CVD, glucose metabolism, and smoking status (model 1) and other cardiovascular risk factors, ie, SBP (model 2), dyslipidemia (model 3), and microalbuminuria (model 4). Second, the contributions of the regional fat and lean mass, estimated by either DXA or anthropometrics, were analyzed in mutually adjusted models. In both sets of analyses, the potential mediating role of low-grade inflammation (hsCRP) was investigated by calculating the magnitude of the changes in the regression coefficients after further adjustment for this variable. All results are shown as standardized regression coefficients (␤) and the respective 95% confidence intervals (CIs) and were performed in men and women separately. Assumption of linearity intrinsic to the method of data analyses adopted was checked by inspection of the residuals by predicted values scatter plots. 23 We considered the stability of the models to be disturbed by multicolinearity if the tolerance was Ͻ0.1. 23 A 2-sided probability value of Ͻ0.05 was considered statistically significant. All analyses were performed by using the Statistical Package for Social Sciences (SPSS) for Windows, version 15.0 (SPSS Inc., Chicago, Ill).
Results
Participants who were excluded from the analyses (nϭ62) were older; had a higher BMI and waist circumference; and more often had hypertension, dyslipidemia, diabetes, and prior CVD than those included (data not shown). The clinical characteristics of the participants included (nϭ586) are shown in Table 1 , stratified by sex. Women had smaller waist but larger hip circumferences and higher levels of total, trunk, and peripheral fat but less lean mass than men. Men and women did not differ with respect to thrombin generation parameters.
Total Body Fat and Thrombin Generation
Total body fat percentage (as estimated by DXA) or BMI, both estimates of total body adiposity, were positively associated with lag time, peak height, and ETP in women, whereas no such associations were seen in men. These associations were independent of age, prior CVD, glucose metabolism, and smoking status (Table 2, model 1) and are also illustrated in Figure 1B , showing the differences in these parameters across categories of BMI. Additional adjustment for SBP (model 2), dyslipidemia (model 3), or microalbuminuria (model 4) only slightly attenuated the associations with lag time and peak height and ETP. The strengths of the associations were comparable for total both body fat percentage (estimated by DXA) and BMI.
Regional Body Composition and Thrombin Generation
DXA Trunk fat and peripheral fat mass were both positively associated with lag time, peak height, and ETP, again in women but not in men. Peripheral lean mass was positively associated with lag time only (Table 3 , model 0). When adjusted for each other, trunk fat, not peripheral fat or lean masses, was the strongest correlate of lag time, peak height, and ETP (Table 3 , model 2; Figure 2 ). Additional adjustment for SBP (model 3), dyslipidemia (model 4), or microalbuminuria (model 5) attenuated these associations only slightly. In these mutually adjusted analyses, if anything, there was a trend toward an inverse association between peripheral lean mass and peak height and ETP in women (Table 3 , models 2 to 5; Figure 2 ), whereas no association was observed between peripheral fat and study outcomes (Table 3 , models 2 to 5; Figure 2 ).
Waist and Hip Circumferences
The associations between fat distribution as estimated by means of waist and hip circumferences and study outcomes mimicked to a large extent the associations obtained with trunk and peripheral fat and lean masses as estimated by DXA (Table 3 , model 1). After adjusting for hip circumference, the association between waist circumference and lag time and ETP in women was attenuated, whereas the association with peak height was stronger (model 2). Further adjustment for cardiovascular risk factors (models 3 to 5), if anything, only slightly attenuated these associations. The anthropometric estimate of peripheral fat (ie, hip circumference) was positively associated with lag time and ETP in women (Table 3 , model 1). These associations, however, disappeared after adjustment for waist circumference; and if anything, there was a trend toward a protective effect of hip circumference on peak height. Furthermore, there was a trend toward an inverse association between hip circumference and ETP in men (model 1), which became stronger after further adjustment waist circumference (model 2) and other cardiovascular risk factors (models 3 to 5).
Potential Mediation Role of Low-Grade Inflammation
The positive associations of estimates of total body fat (ie, total body fat percentage or BMI) and a central pattern of fat accumulation (ie, trunk fat mass or waist circumference) with the thrombin generation parameters observed in women were attenuated when further adjusted for hsCRP (Table 4) .
Additional Analyses
Additional adjustment for use of platelet aggregation inhibitors or lipid-, blood pressure-, or glucose-lowering drugs did not materially affect any of the reported associations (data not shown). Excluding the few individuals who had an albuminto-creatinine ratio above 30 mg/mmol (ie, macroalbuminuria, nϭ5) from the analyses also did not materially affect any of the results.
Associations that were similar to those described above but slightly less strong were found when, instead, we used the thrombin generation parameters estimated in the presence of thrombomodulin (data not shown).
Finally, we also investigated whether the associations between body composition and thrombin generation parameters differed across age categories by adding interaction terms into our models, but no such interactions were found (probability value for all, Ͼ0.10).
Discussion
The present study had 3 major findings: first, total body fat mass was positively associated with a prolonged lag time, higher peak height, and higher ETP in women but not in men. Second, of the regional fat depots, trunk fat contributed the most to these associations, whereas there was no association with peripheral fat and a trend toward an inverse association with peripheral lean mass. Finally, the association between body fat and thrombin generation was independent of traditional cardiovascular risk factors and was to an important extent attenuated by low-grade inflammation.
Our findings are in line with a pilot study, performed in 13 extremely obese children, which reported a positive association between severe obesity (estimated by BMI) and lag time, peak height, and ETP, 13 and with a recent study showing a significant, weight-loss-related decrease in these thrombin generation parameters in 36 morbidly obese adults 2 years after bariatric surgery. 14 In addition, an association has been found between prothrombin 1.2 fragments and waist circumference in postmenopausal women. 7 In the latter study, a trend towards an inverse association between hip circumference and prothrombin 1.2 fragments was described. Such an inverse association with hip circumference was also observed in our study, but more strongly so in men. This finding could reflect a protective role for either peripheral fat or lean mass. Our analyses with DXA estimates of regional body composition suggested that peripheral lean (but not fat) mass counteracted the adverse effects of central fat in this study.
The prolonged lag time in individuals with greater levels of body fat may be attributable to increased TF pathway inhibitor levels, which is one of the main determinants of lag time at the low TF concentrations used. 24 Elevated TF pathway inhibitor levels have been reported in individuals with impaired glucose tolerance and type 2 diabetes, 25 and it has been suggested that this could be due to related obesity. 26 The reason why (central) body fatness was associated with thrombin generation only in women is unclear. Men and women differ with respect to total adiposity and fat distribution in that women store more fat in subcutaneous areas, especially in the gluteal and thigh regions, whereas men accumulate fat preferentially in the upper-body and visceral compartments. Effect modification by sex in the association between (central) fat and thrombin generation could be partially attributable to underlying hormonal differences between the sexes. For instance, sex-specific patterns in growth hormone secretion and aging-related changes in sex-steroid hormonal balance are associated with preferential accumulation of fat in the upper body, 27 and both have been also associated with coagulation and thrombosis. 28, 29 In the present study, no such hormonal data were obtained, and therefore we cannot further determine their potential role. Other obesity-related sex-specific factors may, however, play a role as well. Several studies have found that (older) women have higher levels of low-grade inflammation than men with comparable levels of obesity and that the association between central obesity and hsCRP is stronger in women than men. 30, 31 Indeed, in the present study, the association between central fat mass and hsCRP was also stronger in women than in men (age, prior CVD, glucose metabolism, and smoking status adjusted standardized ␤ women : 0.33 [95%CI, 0.22 to 0.44] versus ␤ men : 0.23 [0.12 to 0.34]; probability value for interaction, Ͻ0.10), and indeed, the associations between central fatness and thrombin generation in women were, to an important extent (up to 55%), attenuated by low-grade inflammation. Nevertheless, and albeit statistically significant, differences between men and women as reported in this study, as well as their underlying biological mechanisms, if any, need to be examined in future studies.
Previous cross-sectional studies have shown positive associations between hsCRP and prothrombin 1.2 fragments in individuals with and without prior CVD. 32, 33 One proposed mechanism by which hsCRP, or low-grade inflammation in general, may lead to increased thrombin generation may be by inducing endothelial dysfunction, which in turn leads to increased TF secretion by monocytes, 34 a phenomenon observed only in the presence of and through direct interaction with other leukocytes. 35 On the basis of this evidence and also on the well-established association between (central) obesity and low-grade inflammation, 15 we hypothesized that lowgrade inflammation could mediate the positive associations between (central) fatness and thrombin generation. Our findings indeed seemed to support this hypothesis. However, the relationship between inflammation and coagulation may be bidirectional, as activated coagulation proteases may affect specific cellular receptors on inflammatory and endothelial cells, thereby modulating an inflammatory response. 36 When we reanalyzed our data under this alternative hypothesis, we found no appreciable "mediation effects" of thrombin generation in the associations between (central) obesity and lowgrade inflammation (hsCRP) (data not shown). An alternative hypothesis that we cannot discard on the basis of the design of the present study is that inflammation and thrombin generation are both elevated as a consequence of (central) obesity without being causally related to each other. Additional mechanistic studies investigating the cross-talk, if any, between hsCRP but also other proinflammatory adiposetissue-related factors (such as interleukin-6, intercellular adhesion molecule, serum amyloid A, and leptin) and thrombin generation, and the extent to which any such associations differ between sexes, are thus warranted.
Not only an increased procoagulant activity but also a decreased anticoagulant activity may lead to higher thrombin generation. When thrombin generation is measured in the presence and absence of thrombomodulin, an estimate of the function of the anticoagulant protein C system is obtained. In our study, no association was found between body composition and the thrombomodulin ratio. This indicates that body fat and its distribution are not associated with abnormalities in protein C activation, which is in line with a previous study in individuals with morbid obesity. 37 Strengths of our study were the assessment of both anthropometric and more precise estimates of body composition (DXA) and the investigation of how both types of estimates of body composition related to thrombin generation. We found that the strength of the associations between BMI and waist circumference or total body fat percentage and its distribution, measured by DXA, on the one hand and thrombin generation on the other were similar. This suggests that in large epidemiological studies on obesity-related hypercoagu- lability, anthropometric estimates of obesity/fat distribution might be a reliable alternative to DXA or other objective estimates of body composition when these are unavailable. In addition, the body composition-thrombin generation associations were investigated in a relatively large population-based group of extensively described individuals, [17] [18] [19] which allowed adjustment for many other cardiovascular risk factors, such as hypertension, dyslipidemia, smoking, and microalbuminuria. Finally, the CAT method we used to estimate thrombin generation mimics the overall potential to clot whenever a thrombogenic stimulus (eg, TF release after plaque rupture) appears. In theory, this method may give a more reliable estimation of coagulation under pathophysiological conditions than the single-point measurement of activation markers, such as prothrombin 1.2 fragments or thrombin-antithrombin complexes. 38 However, prospective studies comparing the value of these measures in the prediction of prothrombotic events are needed to further clarify this issue.
There are some limitations to our study. First, because of its cross-sectional design, any inferences about causality should be made with caution. Second, because fat measures are strongly related to each other, it can be argued that adjustment of these measurements for each other (eg, Table  3 ) was not adequate, leading to overcorrected models. However, although the regression coefficients changed considerably after mutual adjustments for other body composition variables, our analyses were not disturbed by multicolinearity (ie, tolerance was Ͼ0.1 in all models). In fact, these analyses allowed us to tease apart the relative contributions of different fat depots and lean mass in the associations examined. Still, the clinical relevance of the obesity-related elevations in thrombin generation observed in the present study needs to be clarified, as the strength of the associations we found were, albeit significant, relatively weak (and body fatness explained only up to 5% of the variance in the parameters investigated). Third, despite the fact that trunk fat as assessed by DXA correlates highly with intraabdominal fat, it does not distinguish between subcutaneous and visceral fat in the trunk/ abdominal region. 39 Whether the associations of thrombin generation with visceral fat differ from those with (abdominal) subcutaneous fat need to be further examined. Finally, we studied a white, elderly population, and it remains to be established whether the results can be generalized to other ethnicities and to younger individuals.
In conclusion, we have shown that, in women, total body fat is positively associated with thrombin generation in plasma. Of the regional fat depots, central fat mass was the strongest contributor to this association, which may be explained, at least in part, by central-obesity related lowgrade inflammation. Prospective and mechanistic studies are needed to further clarify the mechanisms underlying the obesity-thrombin generation relationships and to ascertain the extent to which higher thrombin generation explains the excess of atherothrombotic events associated with obesity.
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